{
  "meta": {
    "title": "Glycogen_Metabolism",
    "url": "https://brainandscalpel.vercel.app/glycogen-metabolism-ec85d63f.html",
    "scrapedAt": "2025-11-29T18:23:12.470Z"
  },
  "questions": [
    {
      "id": 9324,
      "choices": [
        {
          "id": 37263,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystathionine synthase&nbsp;&nbsp;&nbsp;</span></p>"
        },
        {
          "id": 37264,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoxanthine-guanine phosphoribosyl transferase&nbsp;&nbsp;&nbsp;</span></p>"
        },
        {
          "id": 37265,
          "text": "<p><span style=\"font-size:12.0pt;\">Homogentisic acid oxidase</span></p>"
        },
        {
          "id": 37266,
          "text": "<p><span style=\"font-size:12.0pt;\">Hexosaminidase A&nbsp;</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 4-year-old boy with developmental delay and a behavioral history of self-injurious actions, including tongue biting and finger biting to the point of needing bandages, is brought to a pediatric neurologist. Based on the clinical presentation, which enzyme deficiency is most likely responsible for this condition?</span></p>",
      "unique_key": "Q1639108",
      "question_audio": null,
      "question_video": null,
      "map_id": 29779,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. Hypoxanthine-guanine phosphoribosyl transferase.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The <strong>combination of retardation </strong>and <strong>self-mutilation</strong> helps in arriving at the diagnosis of <strong>Lesch-Nyhan disease.&nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hypoxanthine-guanine phosphoribosyl transferase (HGPRT) is part of the purine salvage pathway and its deficiency results in the inability to recycle purines ü°™ overproduction of uric acid.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>C/F-</strong> Mentally retarded, hyperuricemia, gout and engage in compulsive self-destructive behaviors.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Cystathionine synthase</strong>: Deficiency results in <strong>homocystinuria,</strong> characterized by <strong>elevated urinary homocysteine.</strong> C/F- failure to thrive and visual problems due to lens displacement.&nbsp; Also deficiency of methionine synthase, pyridoxine, folate, or vitamin B12 can cause homocystinuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Homogentisic acid oxidase:</strong> Deficiency results in <strong>alkaptonuria.</strong> C/F- dark urine and darkening of connective tissue (e.g., ear cartilage may appear bluish).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Hexosaminidase A:</strong> Deficiency causes <strong>Tay-Sachs disease</strong> ü°™ results in the accumulation of GM2 ganglioside. C/F-mental retardation, blindness with cherry-red spot on the macula and muscular weakness.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Lesch-Nyhan syndrome</strong>, a disorder caused by a<strong> deficiency </strong>in the <strong>enzyme hypoxanthine-guanine phosphoribosyl transferase </strong>(HPRT), and its deficiency leads to the <strong>overproduction of uric acid </strong>and a <strong>host of neurological </strong>and <strong>behavioral abnormalities</strong>, including <strong>self-mutilation behaviors.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Lippincott 7/e: P 296-297.</strong></span></p>",
      "correct_choice_id": 37264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9315,
      "choices": [
        {
          "id": 37227,
          "text": "<p><span style=\"font-size:12.0pt;\">PRPP synthetase decreased activity can contribute to gout by increasing purine synthesis</span></p>"
        },
        {
          "id": 37228,
          "text": "<p><span style=\"font-size:12.0pt;\">Sodium urate crystals can deposit in kidneys and impair renal function</span></p>"
        },
        {
          "id": 37229,
          "text": "<p><span style=\"font-size:12.0pt;\">Uric acid overproduction is seen in myeloproliferative disorders like leukemia</span></p>"
        },
        {
          "id": 37230,
          "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol used in treatment as it inhibits xanthine oxidase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old female presents to the orthopedic outpatient department with joint swelling and pain, as depicted in the image. The physical examination reveals swollen, erythematous joints with tenderness. Laboratory tests show elevated serum uric acid levels. She is diagnosed with gout. Which of the following statements regarding her condition is incorrect?</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/1_MMDSPFz.jpg\" alt=\"\" width=\"255\" height=\"179\"></span></p>",
      "unique_key": "Q1654629",
      "question_audio": null,
      "question_video": null,
      "map_id": 29771,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. PRPP synthetase decreased activity can contribute to gout by increasing purine synthesis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. PRPP synthetase decreased activity can contribute to gout by increasing purine synthesis ‚Äì Incorrect (Correct Answer)</strong></span><br><span style=\"font-size:12.0pt;\">This is <strong>incorrect</strong> because <strong>decreased activity</strong> of PRPP synthetase <strong>reduces</strong> purine synthesis. In contrast, <strong>increased (not decreased) activity</strong> of PRPP synthetase leads to <strong>enhanced purine synthesis</strong> and overproduction of uric acid, contributing to <strong>gout.</strong> Therefore, the statement is wrong.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option B. Sodium urate crystals can deposit in kidneys and impair renal function ‚Äì&nbsp; True</strong></span><br><span style=\"font-size:12.0pt;\">In <strong>chronic gout</strong>, urate crystals can deposit in the renal parenchyma and tubules, leading to <strong>urate nephropathy</strong> and potential <strong>renal failure.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Uric acid overproduction is seen in myeloproliferative disorders like leukemia ‚Äì True</strong></span><br><span style=\"font-size:12.0pt;\"><strong>Leukemias and other myeloproliferative disorders</strong> involve rapid cell turnover and breakdown of nucleic acids, leading to <strong>hyperuricemia</strong> and secondary gout.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Allopurinol used in treatment as it inhibits xanthine oxidase ‚Äì True</strong></span><br><span style=\"font-size:12.0pt;\"><strong>Allopurinol</strong> is a <strong>inhibitor</strong> of xanthine oxidase, reducing the conversion of hypoxanthine and xanthine to uric acid, making it effective for long-term management of gout.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understand that <strong>gout</strong> can result from overactivity of <strong>PRPP synthetase</strong>, leading to <strong>increased de novo purine synthesis</strong> and elevated uric acid production. Treatments like <strong>allopurinol</strong> target <strong>xanthine oxidase</strong> to reduce uric acid synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30 /e: p 354.</span></p>",
      "correct_choice_id": 37227,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9317,
      "choices": [
        {
          "id": 37235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose 1-phosphate</span></span></span></p>"
        },
        {
          "id": 37236,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fructose 1,6-bisphosphate</span></span></span></p>"
        },
        {
          "id": 37237,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Uridine diphosphate </span></span></span></p>"
        },
        {
          "id": 37238,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cytosine diphosphate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old male presents to the clinic with the laboratory findings of reducing substances in his urine that are not glucose, signs of liver disease, and decreased liver glycogen observed in a liver biopsy. To identify the underlying cause of his symptoms, which of the following metabolite concentrations should be measured?</span></span></p>",
      "unique_key": "Q1590096",
      "question_audio": null,
      "question_video": null,
      "map_id": 29772,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Uridine diphosphate </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>UDP-glucose </strong>is the <strong>activated form of glucose </strong>utilized for the <strong>synthesis of glycogen </strong>and <strong>Galactose</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is <strong>formed from the reaction </strong>of <strong>glucose1-phosphate </strong>and <strong>UTP</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>conversion of galactose </strong>to <strong>glucose </strong>is at the <strong>UDP-sugar level</strong>, which is deficient in galactosemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>UDP derivatives </strong>of <strong>glucose</strong>, <strong>galactose </strong>and <strong>sugar amines </strong>are key precursors for<strong> synthesis of cerebrosides </strong>and <strong>gangliosides</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A</span></strong><span style=\"font-size:12.0pt\">. <strong>Glucose 1-phosphate </strong>and <strong>Option B</strong>. <strong>Fructose 1,6-bisphosphate</strong>: The <strong>glucose or fructose phosphates regulates glycogen </strong>stores but will not prevent synthesis of glycogen or block galactose metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. <strong>Cytosine diphosphate</strong>: It is important for the <strong>synthesis of phospholipids</strong>, thus <strong>forming high-energy CDP diacylglycerol </strong>which <strong>transfers diacylglycerol </strong>to <strong>form phosphatidylinositol&rsquo;s </strong>(signal transducers) and <strong>cardiolipin </strong>(seen in mitochondrial membrane and develops antibodies in autoimmune disorders)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>presence of non-glucose reducing substances </strong>in <strong>urine </strong>and <strong>reduced liver glycogen</strong>, with <strong>elevated UDP-sugars</strong>, indicates a <strong>glycogen storage disease </strong>like <strong>GSD Type Ia</strong>. Diagnosing involves measuring UDP concentrations to reveal a block in the metabolic pathway involving glucose-6-phosphatase.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Harper 30 /e: p 116,177,201, 571.</span></strong></span></span></p>",
      "correct_choice_id": 37237,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9318,
      "choices": [
        {
          "id": 37239,
          "text": "<p><span style=\"font-size:12.0pt;\">9</span></p>"
        },
        {
          "id": 37240,
          "text": "<p><span style=\"font-size:12.0pt;\">7</span></p>"
        },
        {
          "id": 37241,
          "text": "<p>4</p>"
        },
        {
          "id": 37242,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A research team is evaluating the effects of azaserine, a drug known to inhibit glutamine-dependent enzymes, on nucleotide synthesis. In considering the drug's impact on purine biosynthesis, Nitrogen atom at which position in the generic purine structure is Contributed by Glutamine?</span></p>",
      "unique_key": "Q6714458",
      "question_audio": null,
      "question_video": null,
      "map_id": 29773,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. 9</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Purine biosynthesis involves building the purine ring step by step on a ribose-5-phosphate backbone. Various atoms of the purine ring come from different precursors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glutamine provides nitrogen atoms via its amide nitrogen (-NH2) in the purine biosynthesis pathway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>In purine biosynthesis:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-14%20165313.png\" width=\"747\" height=\"396\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus, glutamine donates nitrogen at:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">N3</span></li><li><span style=\"font-size:12.0pt;\">N9</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the context of your question (specifically asking for ‚Äúthe nitrogen contributed by glutamine‚Äù), position 9 is one of the key sites.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 7:&nbsp;</strong>N7 comes from glycine, not glutamine. Glycine contributes two carbons and one nitrogen (C4, C5, N7).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 4:&nbsp;</strong>C4 comes from glycine as well. Glycine contributes to the entire C4-C5-N7 chain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 1:&nbsp;</strong>N1 comes from aspartate, not glutamine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Purine biosynthesis is a multi-step process that builds the purine ring atom by atom using various precursors:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Glutamine‚Äôs amide nitrogen provides N3 and N9.</span></li><li><span style=\"font-size:12.0pt;\">Glycine donates C4, C5, and N7.</span></li><li><span style=\"font-size:12.0pt;\">Aspartate provides N1.</span></li><li><span style=\"font-size:12.0pt;\">Formyl-THF (N10-formyl-tetrahydrofolate) donates C2 and C8.</span></li><li><span style=\"font-size:12.0pt;\">CO2 (bicarbonate) supplies C6.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Inhibition of glutamine-dependent enzymes (like by azaserine) disrupts steps that require glutamine as an amide donor, blocking Nitrogen incorporation and thus halting purine biosynthesis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e p 348-349.</span></p>",
      "correct_choice_id": 37239,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9320,
      "choices": [
        {
          "id": 37247,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decreased temperature </span></span></span></p>"
        },
        {
          "id": 37248,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decreased blood flow</span></span></span></p>"
        },
        {
          "id": 37249,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Exposure to sunlight</span></span></span></p>"
        },
        {
          "id": 37250,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increased blood flow</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male with a history of chronic alcohol abuse presents to the clinic with pain and swelling in the joints of his hands, as shown in the picture. The condition is characterized by the formation and deposition of sodium urate crystals in peripheral joints. Which of the following factors is known to contribute to the formation of these urate crystals?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/4_8KN4vL5.jpg\" style=\"height:209px; width:280px\" /></span></span></span></p>",
      "unique_key": "Q4722488",
      "question_audio": null,
      "question_video": null,
      "map_id": 29776,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Decreased temperature</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Hyperuricemia</strong> (gout) is a clinical condition characterized by <strong>elevated levels of uric acid</strong> that <strong>lead to the formation </strong>of <strong>sodium urate crystals.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Uric acid</strong> has a <strong>pKa of 5.4 </strong>and is <strong>ionized</strong> in the <strong>body to form urate,</strong> which is not very soluble in an aqueous environment and the quantity of urate in human blood is also very close to the solubility range. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">So, any <strong>situations </strong>which <strong>leads to excessive degradation of purine </strong>bases can <strong>increase the urate concentration </strong>past the solubility point &rarr; formation of urate crystals. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>decreased body temperature </strong>seen in the <strong>joints contributes</strong> to the <strong>formation of urate crystals</strong> under these conditions.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong><span style=\"font-size:12.0pt\"> <strong>Decreased blood flow:</strong> While <strong>decreased blood flow </strong>might theoretically <strong>lead to increased concentration</strong> of <strong>uric acid,</strong> it is not typically cited as a direct contributor to crystal formation. Gout flares are not commonly associated with decreased blood flow.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Exposure to sunlight</strong>: <strong>Sunlight exposure</strong> does <strong>not affect the solubility of uric acid</strong> and is not a recognized factor in the formation of urate crystals.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> <strong>Increased blood flow: </strong>Increased blood flow would generally <strong>improve the elimination of uric acid</strong> through the <strong>kidneys </strong>and is not associated with the <strong>formation of urate crystals</strong>. However, increased blood flow can lead to the inflammatory response seen with gout flares once the crystals have formed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Decreased temperature</strong> can <strong>lead to urate crystal formation in peripheral joints </strong>is important for understanding why <strong>gout</strong> commonly <strong>affects the cooler distal joints </strong>and how <strong>acute attacks</strong> may be <strong>precipitated by changes in temperature.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Harper 30/esp. 354, Lippincott 7/ed: p 301.</span></strong></span></span></p>",
      "correct_choice_id": 37247,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9325,
      "choices": [
        {
          "id": 37267,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Competitive inhibitor of xanthine oxidase &amp; decrease UA formation</span></span></span></p>"
        },
        {
          "id": 37268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase renal excretion of urate</span></span></span></p>"
        },
        {
          "id": 37269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reduce body uric acid pool</span></span></span></p>"
        },
        {
          "id": 37270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Arrest the arthritis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male presents with sudden onset of severe pain in his right big toe, extending up to the knee, which began in the morning. The pain developed after a night of alcohol consumption. On examination, the affected big toe is swollen, tender, and warm. Laboratory tests reveal a serum uric acid level of 9.6 mg/dl. After being prescribed allopurinol by the physician, the patient&#39;s symptoms improved within three days. What is the mechanism of action of allopurinol in the treatment of hyperuricemia?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/6_xcRX0L4.jpg\" style=\"height:165px; width:244px\" /></span></span></span></p>",
      "unique_key": "Q1877002",
      "question_audio": null,
      "question_video": null,
      "map_id": 29780,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Competitive inhibitor of xanthine oxidase &amp; decrease UA formation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is diagnosed to have <strong>Gout.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Allopurinol</strong> is a <strong>competitive inhibitor of xanthine oxidase </strong>&rarr; <strong>decreases the formation of uric acid.</strong> Xanthine and hypoxanthine are more soluble and are easily excreted.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Xanthine oxidase </strong>converts <strong>allopurinol to alloxanthin,</strong> which is a more effective inhibitor of xanthine oxidase. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is a good example of <strong>&lsquo;suicide inhibition&#39;.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">. <strong>Increase the renal excretion of urate by decreasing the reabsorption of urate from kidney tubules:</strong> Action of <strong>uricosuric drugs. </strong>e.g., probenecid.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Reduce body uric acid pool</strong>: done by <strong>PEG</strong> (polyethylene glycol) <strong>uricase </strong>and <strong>conversion of urate to allantoin</strong> (more water soluble and easily excreted).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. <strong>Arrest the arthritis:</strong> Action of <strong>Colchicine</strong>, an <strong>anti-inflammatory agent.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Allopurinol </strong>is a <strong>structural analog of hypoxanthine.</strong> It acts as a <strong>competitive inhibitor </strong>of <strong>xanthine oxidase</strong>, an <strong>enzyme</strong> responsible for <strong>converting hypoxanthine</strong> to <strong>xanthine</strong> and <strong>xanthine to uric acid</strong>. By <strong>inhibiting this enzyme</strong>, <strong>allopurinol reduces </strong>the <strong>production</strong> of <strong>uric acid,</strong> thereby <strong>treating hyperuricemia</strong> which is often associated with gout.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Harper 30/e:&nbsp; p 344.</span></strong></span></span></p>",
      "correct_choice_id": 37267,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9330,
      "choices": [
        {
          "id": 37287,
          "text": "<p><span style=\"font-size:12.0pt;\">5-Methyl thymidine</span></p>"
        },
        {
          "id": 37288,
          "text": "<p><span style=\"font-size:12.0pt;\">Ara C</span></p>"
        },
        {
          "id": 37289,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphoribosylamine</span></p>"
        },
        {
          "id": 37290,
          "text": "<p><span style=\"font-size:12.0pt;\">5-Phosphoribosylpyrophosphate (PRPP)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the complex biochemical pathway of purine biosynthesis, certain substrates are crucial for the synthesis of the purine nucleotides. Among the following options, which compound is a necessary substrate for the initiation and progression of purine biosynthesis?</span></p>",
      "unique_key": "Q6326233",
      "question_audio": null,
      "question_video": null,
      "map_id": 29782,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. 5-Phosphoribosylpyrophosphate (PRPP)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Purine biosynthesis starts with the formation of PRPP (5-Phosphoribosyl-1-pyrophosphate), a key activated ribose sugar donor.</span></p><p><span style=\"font-size:12.0pt;\">PRPP + Glutamine ‚Üí 5-Phosphoribosylamine (the <i>first committed step</i> in purine biosynthesis).</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">PRPP is synthesized from ribose-5-phosphate by the enzyme PRPP synthetase.</span></li><li><span style=\"font-size:12.0pt;\">It serves as the foundation onto which the purine ring is built step-by-step.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus, PRPP is essential at both initiation and progression stages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 5</strong>-Methyl thymidine:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">This is a nucleoside derivative of thymine (used in DNA), not involved in purine biosynthesis (purines = adenine &amp; guanine).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ara C (Cytarabine):</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">This is a chemotherapy drug, a cytidine analog used to inhibit DNA synthesis‚Äînot a substrate for purine biosynthesis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Phosphoribosylamine:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">This compound is an intermediate (formed <i>after</i> PRPP reacts with glutamine).</span></li><li><span style=\"font-size:12.0pt;\">It's not a substrate to initiate purine biosynthesis, but a product of the first committed step.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Purine biosynthesis requires PRPP as a substrate.</span></li><li><span style=\"font-size:12.0pt;\">The first committed step is catalyzed by glutamine-PRPP amidotransferase, converting PRPP ‚Üí phosphoribosylamine.</span></li><li><span style=\"font-size:12.0pt;\">This sets the stage for ring assembly to eventually produce IMP (inosine monophosphate), the precursor of AMP &amp; GMP.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: DM Vasudevan 9/e: p 583.</span></p>",
      "correct_choice_id": 37290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9333,
      "choices": [
        {
          "id": 37299,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adenosine 5&rsquo; monophosphate (AMP)</span></span></span></p>"
        },
        {
          "id": 37300,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inosine 5&rsquo; monophosphate (IMP)</span></span></span></p>"
        },
        {
          "id": 37301,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Xanthine 5&rsquo; monophosphate (XMP)</span></span></span></p>"
        },
        {
          "id": 37302,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Guanosine 5&rsquo; monophosphate (GMP)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which one of the nucleotide is first formed by the de novo purine biosynthesis:&nbsp;</span></span></p>",
      "unique_key": "Q7115971",
      "question_audio": null,
      "question_video": null,
      "map_id": 29783,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Inosine 5&rsquo; monophospahte (IMP)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>regulatory enzymes</strong> of <strong>Purine Synthesis </strong>are <strong>PRPP Synthase</strong> and <strong>PRPP Glutamyl Amido transferase</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>rate limiting step</strong> of <strong>de novo Purine Synthesis</strong> is <strong>PRPP Glutamyl amidotransferase</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>PRPP level </strong>determines the <strong>de novo purine synthesis,</strong> which activates PRPP Synthase.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>rate of PRPP Synthesis</strong> depends on the <strong>availability of ribose 5 Phosphate</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">AMP, ADP, GMP and GDP the end products of de novo Purine synthesis feedback regulate PRPP Synthase and PRPP Glutamyl Amidotransferase.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>First Nucleotide </strong>formed in <strong>Purine Synthesis-Inosine Mono Phosphate</strong> (IMP)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/10_jBCykse.jpg\" style=\"height:412px; width:602px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong><span style=\"font-size:12.0pt\"> <strong>Adenosine 5&rsquo; monophosphate </strong>(AMP): AMP is <strong>synthesized from IMP</strong> and not directly formed during the initial steps of de novo purine biosynthesis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Xanthine 5&rsquo; monophosphate</strong> (XMP): XMP is an <strong>intermediate in the pathway of purine metabolism</strong> but not the first nucleotide formed in the de novo synthesis of purines.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> <strong>Guanosine 5&rsquo; monophosphate</strong> (GMP): Like AMP, <strong>GMP</strong> is <strong>derived from IMP </strong>and is not the initial product of the de novo purine biosynthesis pathway.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Inosine 5&rsquo; monophosphate</strong> (IMP) is the <strong>first nucleotide</strong> produced in the <strong>de novo purine biosynthesis pathway.</strong> This <strong>pathway builds</strong> the <strong>purine ring molecule</strong> by <strong>molecule onto the ribose sugar.</strong> Once <strong>IMP is synthesized,</strong> it can then be further <strong>converted into other purine nucleotides,</strong> such as <strong>adenosine 5&rsquo; monophosphate</strong> (AMP) and <strong>guanosine 5&rsquo; monophosphate </strong>(GMP), through a series of specific enzymatic reactions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 7/e: p 583.</span></span></strong></p>",
      "correct_choice_id": 37300,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9319,
      "choices": [
        {
          "id": 37243,
          "text": "<p><span style=\"font-size:12.0pt;\">Amide nitrogen of glutamine</span></p>"
        },
        {
          "id": 37244,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspartate</span></p>"
        },
        {
          "id": 37245,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycine</span></p>"
        },
        {
          "id": 37246,
          "text": "<p><span style=\"font-size:12.0pt;\">N10 formyl THFA</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following correctly identifies the nitrogen sources for N3 &amp; N9 positions in Purine Ring?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/2_w4k7Xi6.jpg\" alt=\"\" width=\"400\" height=\"252\"></span></p>",
      "unique_key": "Q4008488",
      "question_audio": null,
      "question_video": null,
      "map_id": 29775,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Amide nitrogen of glutamine</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>CONTRIBUTORS OF PURINE RING:&nbsp;</strong>&nbsp;&nbsp;&nbsp;</span></p><p style=\"text-align:justify;\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/3_6AxmNES.jpg\" alt=\"\" width=\"500\" height=\"318\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B.</strong> <strong>Aspartate </strong>‚Äì contributes N1 of PURINE ring.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Glycine </strong>- contributes N7 of PURINE ring.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>N10 formyl THFA</strong>- contributes C8 of PURINE ring.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In the <strong>biosynthesis of purines</strong>, the <strong>nitrogen atoms at positions N3 </strong>and <strong>N9 originate</strong> from the <strong>amide nitrogen of glutamine.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Harper 30/e: p 347-348.</strong></span></p>",
      "correct_choice_id": 37243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6459,
      "choices": [
        {
          "id": 25805,
          "text": "<p><span style=\"font-size:12pt;\">Glycogen storage disease type I&nbsp;</span></p>"
        },
        {
          "id": 25806,
          "text": "<p><span style=\"font-size:12pt;\">Hereditary Fructose intolerance</span></p>"
        },
        {
          "id": 25807,
          "text": "<p><span style=\"font-size:12pt;\">Both a and b</span></p>"
        },
        {
          "id": 25808,
          "text": "<p><span style=\"font-size:12pt;\">Only b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the context of infantile conditions, hypoglycemia is observed in which of the following?</span></p>",
      "unique_key": "Q9109924",
      "question_audio": null,
      "question_video": null,
      "map_id": 29769,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Both a and b</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Both <strong>Glycogen Storage Disease Type I (GSD I)</strong> and <strong>Hereditary Fructose Intolerance (HFI)</strong> can lead to <strong>hypoglycemia</strong>, particularly in infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Glycogen Storage Disease Type I (Von Gierke Disease)</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Caused by a <strong>deficiency of glucose-6-phosphatase</strong>.</span></li><li><span style=\"font-size:12.0pt;\">This enzyme is crucial for the <strong>final step of gluconeogenesis and glycogenolysis</strong>, converting glucose-6-phosphate to free glucose.</span></li><li><span style=\"font-size:12.0pt;\">Without it, the liver cannot release glucose into the bloodstream ‚Üí <strong>severe fasting hypoglycemia</strong>, typically noticed shortly after birth.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Hereditary Fructose Intolerance (HFI)</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Caused by a <strong>deficiency of aldolase B</strong>.</span></li><li><span style=\"font-size:12.0pt;\">When <strong>fructose, sucrose, or sorbitol</strong> is introduced (e.g., via formula or weaning), <strong>fructose-1-phosphate accumulates</strong>, which:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Traps phosphate</span></li><li><span style=\"font-size:12.0pt;\">Inhibits <strong>glycogenolysis</strong></span></li></ul></li><li><span style=\"font-size:12.0pt;\">Leads to <strong>hypoglycemia</strong> and other symptoms like <strong>vomiting</strong>, <strong>hepatomegaly</strong>, and <strong>failure to thrive</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note</strong>: HFI typically manifests <strong>after exposure to fructose-containing foods</strong>, so it may not present <strong>immediately after birth</strong>, but it is a <strong>cause of hypoglycemia in infants</strong>, especially during weaning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Be aware of <strong>metabolic disorders</strong> that can cause <strong>hypoglycemia in neonates or infants</strong>, particularly:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Glycogen Storage Disease Type I (Von Gierke)</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Hereditary Fructose Intolerance (HFI)</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Galactosemia</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Long-Chain Acyl-CoA Dehydrogenase Deficiency (LCAD)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Vasudevan 9/e: 138.</span></p>",
      "correct_choice_id": 25807,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6412,
      "choices": [
        {
          "id": 25617,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arginase</span></span></span></p>"
        },
        {
          "id": 25618,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid synthase</span></span></span></p>"
        },
        {
          "id": 25619,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogen synthase</span></span></span></p>"
        },
        {
          "id": 25620,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone sensitive lipase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male presents with symptoms of excessive thirst, increased appetite, tiredness, and a thin build. He has been advised to undergo fasting blood sugar (FBS) and postprandial blood sugar (PPBS) tests and is currently 12 hours into his fast. During this period of fasting, which one of the following enzymes is likely to be phosphorylated and active?</span></span></span><br />\r\n&nbsp;</p>",
      "unique_key": "Q8738806",
      "question_audio": null,
      "question_video": null,
      "map_id": 29768,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Hormone sensitive lipase&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hormone sensitive lipase of adipocytes </strong>are <strong>phosphorylated </strong>and activated by <strong>protein kinase A </strong>in response to <strong>epinephrine</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Arginase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Arginase </strong>is an enzyme involved in the <strong>urea cycle</strong>, which converts <strong>arginine into urea and ornithine</strong>. Its activity is <strong>not </strong>directly influenced by <strong>fasting or feeding states</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fatty acid synthase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Fatty acid synthase </strong>is involved in the <strong>synthesis of fatty acids</strong>, a process that is<strong> downregulated </strong>during fasting when the <strong>body is mobilizing</strong>, <strong>rather than storing, energy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glycogen synthase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Glycogen synthase is responsible for <strong>glycogen synthesis in the liver and muscle cells</strong>. This enzyme is <strong>less active </strong>during<strong> fasting</strong>, as the body is <strong>breaking down glycogen stores, not</strong> building them.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hormone-sensitive lipase (HSL)</strong> is an enzyme in <strong>adipose tissue </strong>that breaks down <strong>stored triglycerides into free fatty acids </strong>and <strong>glycerol</strong>, which can then be used for<strong> energy</strong>. HSL is <strong>activated </strong>by <strong>phosphorylation </strong>in response to <strong>low insulin and high glucagon levels</strong>, which are <strong>typical during fasting</strong>. Thus, in a <strong>fasting state</strong>, <strong>HSL</strong> would be <strong>phosphorylated and active </strong>to facilitate the <strong>mobilization of fat stores</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p 261-263</span></strong></span></span></p>",
      "correct_choice_id": 25620,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6015,
      "choices": [
        {
          "id": 24030,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Storage as fructose</span></span></span></p>"
        },
        {
          "id": 24031,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Storage as glyceraldehyde-3-phosphate</span></span></span></p>"
        },
        {
          "id": 24032,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enters HMP shunt via ribulose-5-phosphate</span></span></span></p>"
        },
        {
          "id": 24033,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Storage as glycogen</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman, following a meal rich in carbohydrates, undergoes various metabolic adjustments to manage the influx of glucose. One of these adjustments involves the metabolism of glucose-6-phosphate, a key metabolite in glucose homeostasis. Considering the fed state, where glucose is abundant, what is the primary fate of glucose-6-phosphate in tissues? </span></span></span></p>",
      "unique_key": "Q2583261",
      "question_audio": null,
      "question_video": null,
      "map_id": 29787,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Storage as glycogen</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the <strong>fed state</strong>, the <strong>major fate of glucose-6-phosphate </strong>in <strong>tissues is its conversion </strong>and <strong>storage as glycogen</strong>. This <strong>process </strong>is essential for <strong>maintaining blood glucose levels </strong>within a <strong>narrow range</strong>, especially during <strong>periods of fasting</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Storage as fructose </strong>is <strong>not </strong>a <strong>primary pathway for glucose-6-phosphate metabolism </strong>in tissues during the fed state.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glyceraldehyde-3-phosphate </strong>is an <strong>intermediate in glycolysis</strong>, but the <strong>direct storage of glucose-6-phosphate</strong> as glyceraldehyde-3-phosphate is not a primary fate in the fed state.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>glucose-6-phosphate </strong>can <strong>enter the Hexose Monophosphate </strong>(HMP) <strong>shunt</strong>, this <strong>pathway is primarily active </strong>in <strong>specific tissues </strong>like the <strong>liver</strong>, and its main function is not for storage but for producing NADPH and ribose-5-phosphate for biosynthetic reactions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>uptake of glucose </strong>into the <strong>liver GLUT 2 </strong>is <strong>independent of insulin</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the well fed state &rarr; concentration of glucose entering the liver increases &rarr; increased rate of synthesis of glucose-6-phosphate.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is in excess of the liver&rsquo;s requirement for energy-yielding metabolism. So, it is used mainly for synthesis of glycogen.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>both liver</strong> and <strong>skeletal muscle,</strong> <strong>insulin acts </strong>to <strong>stimulate glycogen synthase</strong> and <strong>inhibit glycogen phosphorylase</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harper 30/e: p148.</span></strong></span></span></p>",
      "correct_choice_id": 24033,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6378,
      "choices": [
        {
          "id": 25481,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver</span></span></span></p>"
        },
        {
          "id": 25482,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle</span></span></span></p>"
        },
        {
          "id": 25483,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both</span></span></span></p>"
        },
        {
          "id": 25484,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following tissues is INCAPABLE of contributing directly to blood glucose levels through glycogen breakdown?</span></span></span></p>",
      "unique_key": "Q5373118",
      "question_audio": null,
      "question_video": null,
      "map_id": 29777,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Muscle</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Muscle tissue </strong>stores <strong>glycogen</strong> for its own<strong> use </strong>and <strong>lacks</strong> the enzyme<strong> glucose-6-phosphatase, </strong>which is required to <strong>convert glucose-6-phosphate into free glucose</strong> that can be <strong>released </strong>into the <strong>bloodstream. </strong>Therefore, <strong>glycogen breakdown in muscle </strong>leads to <strong>glucose</strong>-<strong>6-phosphate </strong>being used primarily within the <strong>muscle cells themselves </strong>for <strong>energy,</strong> particularly during <strong>exercise, </strong>rather than contributing to <strong>systemic blood glucose levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Liver:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The liver is capable of contributing <strong>directly to blood glucose levels </strong>through <strong>glycogen breakdown. </strong>It contains the enzyme <strong>glucose-6-phosphatase, </strong>which allows for the conversion of<strong> glucose-6-phosphate into free glucose </strong>that can be released into the <strong>bloodstream, </strong>thereby maintaining <strong>blood glucose levels</strong>, especially during<strong> fasting</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Both:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is<strong> incorrect</strong> because the<strong> liver</strong> can directly contribute to <strong>blood glucose levels </strong>through <strong>glycogen</strong> <strong>breakdown</strong>, while <strong>muscle cannot.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Differences between Liver Glycogen and Muscle Glycogen.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture13.jpg\" style=\"height:270px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Muscle glycogen </strong>is<strong> not</strong> directly available as a <strong>source of blood glucose</strong> because muscle <strong>lacks glucose-6-phosphatase</strong> which releases <strong>free glucose from glucose 6-P.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p177, 178.</span></strong></span></span></p>",
      "correct_choice_id": 25482,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6375,
      "choices": [
        {
          "id": 25469,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only active during gluconeogenesis</span></span></p>"
        },
        {
          "id": 25470,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Requires Protein Kinase activation</span></span></p>"
        },
        {
          "id": 25471,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enzyme located in the endoplasmic reticulum</span></span></p>"
        },
        {
          "id": 25472,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibited by albumin in the cytoplasm</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old child with frequent hypoglycemic episodes during fasting is being evaluated. Laboratory findings indicate normal glycogen structure but impaired glycogenolysis. Given the critical role of Glucose-6-Phosphatase in this process, why isn&#39;t Glucose-6-Phosphate immediately converted to glucose in hepatocytes?</span></span></span></p>",
      "unique_key": "Q3858190",
      "question_audio": null,
      "question_video": null,
      "map_id": 29774,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Enzyme located in the endoplasmic reticulum</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose-6-Phosphatase,</strong> which catalyzes the <strong>final step in glycogenolysis and gluconeogenesis </strong>by converting <strong>Glucose-6-Phosphate</strong> into <strong>glucose,</strong> is located in the <strong>endoplasmic reticulum (ER) of hepatocytes</strong>. This necessitates the transport of <strong>Glucose-6-Phosphate</strong> from the<strong> cytoplasm to the ER</strong>, a process mediated by <strong>specific translocases</strong>, before it can be <strong>dephosphorylated.</strong> This <strong>spatial</strong> <strong>separation </strong>serves as a<strong> regulatory </strong>mechanism to control <strong>glucose</strong> release into the <strong>bloodstream.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Only active during gluconeogenesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is<strong> incorrect</strong> because <strong>Glucose-6-Phosphatase</strong> is <strong>active</strong> during <strong>both</strong> <strong>gluconeogenesis and glycogenolysis</strong>, <strong>not</strong> exclusively during<strong> gluconeogenesis</strong>. Its activity is crucial for <strong>maintaining blood glucose</strong> <strong>levels</strong>, especially during<strong> fasting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Requires Protein Kinase activation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Glucose-6-Phosphatase</strong> activity is <strong>not </strong>directly regulated by <strong>protein kinases</strong>. The regulation of this enzyme is primarily through<strong> substrate availability</strong> and its <strong>subcellular localization,</strong> rather than through <strong>activation by</strong> <strong>phosphorylation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Inhibited by albumin in the cytoplasm:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> There is <strong>no</strong> direct interaction between <strong>albumin and Glucose-6-Phosphatase</strong> that would <strong>inhibit </strong>its <strong>activity.</strong> <strong>Albumin,</strong> a <strong>serum protein</strong> produced by the<strong> liver,</strong> primarily functions in maintaining <strong>oncotic pressure</strong> and <strong>transporting substances</strong>; it<strong> does not</strong> play a regulatory role in<strong> glycogenolysis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose-6-phosphatase</strong> is in the lumen of the<strong> smooth endoplasmic reticulum</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose-6-phosphate </strong>is transported to<strong> SER </strong>by a transporter known as <strong>translocase</strong> to be acted by <strong>Glucose- 6-phosphatase.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Genetic defects </strong>of the <strong>Glucose-6-phosphate transporter</strong> can result in a variant of <strong>type I glycogen storage disease.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p178.</span></strong></span></span></p>",
      "correct_choice_id": 25471,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6380,
      "choices": [
        {
          "id": 25489,
          "text": "<p>9</p>"
        },
        {
          "id": 25490,
          "text": "<p>18</p>"
        },
        {
          "id": 25491,
          "text": "<p>24</p>"
        },
        {
          "id": 25492,
          "text": "<p>48</p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Approximately how many hours does it take for liver glycogen stores to become significantly depleted in an average adult under normal physiological conditions?</span></span></span></p>",
      "unique_key": "Q3730575",
      "question_audio": null,
      "question_video": null,
      "map_id": 29778,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 18 hours</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Under <strong>normal physiological conditions</strong>,<strong> liver glycogen stores </strong>can sustain <strong>blood glucose levels </strong>for about<strong> 18 hours of fasting. </strong>After this period, the <strong>body increasingly</strong> relies on <strong>gluconeogenesis </strong>and the<strong> breakdown of fats for energy</strong>, marking a<strong> transition in the body&#39;s</strong> primary <strong>energy </strong>sources to maintain <strong>metabolic functions </strong>during <strong>prolonged fasting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Liver and Muscle Glycogen</strong> are generally<strong> exhausted </strong>by <strong>18 hours of fasting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p149.</span></strong></span></span></p>",
      "correct_choice_id": 25490,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6395,
      "choices": [
        {
          "id": 25549,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl-CoA carboxylase</span></span></span></p>"
        },
        {
          "id": 25550,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphate dehydrogenase</span></span></span></p>"
        },
        {
          "id": 25551,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogen phosphorylase</span></span></span></p>"
        },
        {
          "id": 25552,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogen synthase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 18-year-old medical student, immersed in the demanding schedule of clinical rotations, often finds himself skipping lunch and dinner. To sustain his energy levels and cognitive function during these prolonged periods without food, his body must mobilize glucose from liver stores. Which enzyme plays a pivotal role in this process by facilitating the release of glucose from glycogen stored in the liver?</span></span></span></p>",
      "unique_key": "Q8246076",
      "question_audio": null,
      "question_video": null,
      "map_id": 29785,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Glycogen phosphorylase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogen phosphorylase</strong> is the key enzyme involved in <strong>glycogenolysis, </strong>the process of breaking down<strong> glycogen into glucose-1-phosphate,</strong> which is then converted to<strong> glucose-6-phosphate</strong>. This can be further processed to release <strong>free glucose</strong> into the <strong>bloodstream,</strong> particularly from the<strong> liver,</strong> thereby <strong>maintaining blood glucose </strong>levels during<strong> fasting states</strong> or <strong>periods of high energy</strong> <strong>demand. </strong>This enzyme is thus crucial for providing the necessary<strong> glucose to the body, </strong>especially when<strong> dietary intake </strong>is<strong> insufficient </strong>or <strong>delayed, </strong>as in the scenario described.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; Acetyl-CoA carboxylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme is involved in<strong> fatty acid synthesis</strong>, <strong>not</strong> in the mobilization or <strong>release</strong> of <strong>glucose from</strong> <strong>glycogen stores.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glucose-6-phosphate dehydrogenase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme is part of the <strong>pentose phosphate pathway</strong> and is involved in producing <strong>NADPH</strong> and<strong> ribose-5-phosphate</strong>, <strong>rather than</strong> in the direct mobilization of <strong>glucose from stored glycogen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Glycogen synthase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme is responsible for the <strong>synthesis of glycogen from glucose</strong>, the <strong>opposite</strong> process to what is needed in this scenario, where the goal is to <strong>mobilize glucose from glycogen stores.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogen </strong>is the <strong>storage form</strong> of<strong> glucose</strong>, which is an easily mobilizable <strong>fuel store</strong>. When individuals are <strong>deprived of or reduced</strong> intake of <strong>carbohydrate</strong>s, the body responds by <strong>breaking down glycogen stores </strong>in the<strong> liver</strong> in order to maintain <strong>normal blood glucose levels</strong>. The<strong> two main enzymes</strong> involved in the<strong> degradation and synthesis </strong>of </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">glycogen are glycogen phosphorylase (option c) and glycogen synthase (option d),</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> respectively.&nbsp; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The processes of <strong>glycogen synthesis and degradation</strong> are coordinated by a <strong>hormone-triggered cascade </strong>that ensures that when one <strong>enzyme is active,</strong> the<strong> other enzyme is inactive.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 177-180.</span></strong></span></span></p>",
      "correct_choice_id": 25551,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6392,
      "choices": [
        {
          "id": 25537,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum glucose levels</span></p>"
        },
        {
          "id": 25538,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin levels</span></p>"
        },
        {
          "id": 25539,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucagon Level</span></p>"
        },
        {
          "id": 25540,
          "text": "<p><span style=\"font-size:12.0pt;\">Dietary Riboflavin levels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 1-year-old child is brought to the outpatient department by their parents due to concerns of muscle hypotonia, failure to thrive, and an enlarged abdomen. Laboratory tests reveal hypoglycemia and ultrasonography shows hepatomegaly. Following a comprehensive evaluation, the child is diagnosed with a type of glycogen storage disease (GSD). In the context of GSD, the glycogen content in the liver is not influenced by which of the following?</span></p>",
      "unique_key": "Q9209799",
      "question_audio": null,
      "question_video": null,
      "map_id": 29784,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. Dietary Riboflavin levels</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dietary riboflavin (vitamin B2) levels do not directly influence glycogen content in the liver in the context of glycogen storage diseases (GSDs).</span></p><p><span style=\"font-size:12.0pt;\">Riboflavin serves as a precursor for flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which function as cofactors for various oxidation-reduction enzymes. While riboflavin is essential for many metabolic processes, it does not play a direct regulatory role in glycogen synthesis or breakdown in the liver.</span></p><p><span style=\"font-size:12.0pt;\">Glycogen storage diseases are inherited metabolic disorders caused by enzyme deficiencies in glycogen synthesis, breakdown, or regulation pathways. The clinical presentation described in the question (muscle hypotonia, failure to thrive, enlarged abdomen, hypoglycemia, and hepatomegaly) is consistent with several types of GSD.</span></p><p><span style=\"font-size:12.0pt;\">The regulation of hepatic glycogen content primarily depends on hormonal and metabolic factors that directly control glycogen synthesis (glycogenesis) and breakdown (glycogenolysis).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Serum glucose levels</strong> - This is incorrect as a choice for factors that do NOT influence glycogen content.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Serum glucose levels directly affect hepatic glycogen metabolism. High blood glucose promotes glycogen synthesis through activation of glycogen synthase, while low blood glucose levels trigger glycogen breakdown to maintain normoglycemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Insulin levels</strong> - This is incorrect as a choice for factors that do NOT influence glycogen content. Insulin is a key hormone that promotes glycogen synthesis in the liver by:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Activating glycogen synthase (via dephosphorylation)</span></li><li><span style=\"font-size:12.0pt;\">Inhibiting glycogen phosphorylase</span></li><li><span style=\"font-size:12.0pt;\">Increasing glucose uptake and its phosphorylation to glucose-6-phosphate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Glucagon Level</strong> - This is incorrect as a choice for factors that do NOT influence glycogen content. Glucagon has effects opposite to insulin on hepatic glycogen. It promotes glycogenolysis (glycogen breakdown) by:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Activating glycogen phosphorylase via a cAMP-dependent protein kinase cascade</span></li><li><span style=\"font-size:12.0pt;\">Inhibiting glycogen synthase</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In glycogen storage diseases, liver glycogen content is regulated primarily by glucose levels, insulin, Glucagon and factors affecting these parameters (like dietary amino acids).&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture12.jpg\" alt=\"\" width=\"1000\" height=\"236\"></span></p>",
      "correct_choice_id": 25540,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6410,
      "choices": [
        {
          "id": 25609,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proglucagon is synthesized in &alpha; cells of islets of Langerhans</span></span></span></p>"
        },
        {
          "id": 25610,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a straight polypeptide chain with 29 amino acids</span></span></span></p>"
        },
        {
          "id": 25611,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stimulates glycogen synthesis.</span></span></span></p>"
        },
        {
          "id": 25612,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It activates the enzyme glycogen phosphorylase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about glucagon is INCORRECT?</span></span></span></p>",
      "unique_key": "Q6735042",
      "question_audio": null,
      "question_video": null,
      "map_id": 29767,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Stimulates glycogen synthesis.&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a <strong>polypeptide hormone</strong> with <strong>29 amino acids.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is secreted by the<strong> alpha cells of pancreas</strong> as proglucagon precursor.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>t&frac12;: 5 minutes</strong> and<strong> inactivated in the liver.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An<strong> increase in blood glucose level </strong>inhibits secretion of glucagon.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mainly<strong> glycogenolytic </strong>&rarr; active form of <strong>glycogen phosphorylase</strong> is formed under the <strong>influence of glucagon.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Depresses glycogen synthesis</span></span></span></strong></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>other options :</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Proglucagon is synthesized in &alpha; cells of the islets of Langerhans:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>correct</strong>. <strong>Proglucagon</strong> is indeed <strong>synthesized </strong>in the <strong>&alpha; cells, </strong>and through <strong>post-translational</strong> modifications, <strong>glucagon is produced.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It is a straight polypeptide chain with 29 amino acids:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is also <strong>correct</strong>.<strong> Glucagon</strong> is a <strong>peptide hormone</strong> composed of <strong>29 amino acids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It activates the enzyme glycogen phosphorylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>true</strong>. <strong>Glucagon</strong> activates <strong>glycogen phosphorylase</strong>, an enzyme involved in <strong>glycogenolysis,</strong> thereby <strong>promoting</strong> the <strong>breakdown of glycogen</strong> into<strong> glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucagon</strong>, a hormone produced by the <strong>&alpha; cells</strong> of the<strong> islets of Langerhans</strong> in the <strong>pancreas,</strong> plays a crucial role in <strong>glucose metabolism.</strong> Its primary function is to<strong> raise blood glucose levels</strong> by<strong> promoting glycogenolysis </strong>(the breakdown of glycogen to glucose) and <strong>gluconeogenesis</strong> (the synthesis of glucose from non-carbohydrate sources). Therefore, the statement that <strong>glucagon stimulates glycogen synthesis</strong> is <strong>incorrect</strong>, as it actually <strong>promotes glycogen breakdown.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 322</span></strong></span></span></p>",
      "correct_choice_id": 25611,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7646,
      "choices": [
        {
          "id": 30552,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TRUE</span></span></span></p>"
        },
        {
          "id": 30553,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FALSE</span></span></span></p>"
        },
        {
          "id": 30554,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the Above</span></span></span></p>"
        },
        {
          "id": 30555,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not sure</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogenin is often discussed in the context of glycogen synthesis, but there is a common misconception about its nature. Considering the biochemical role of glycogenin, is it accurate to classify it as a polysaccharide?</span></span></span></p>",
      "unique_key": "Q1891766",
      "question_audio": null,
      "question_video": null,
      "map_id": 29770,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) FALSE</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogenin</strong> is <strong>not a polysaccharide</strong>; it is actually a <strong>protein that serves as a primer for glycogen synthesis</strong>. <strong>Glycogenin</strong> <strong>autocatalytically </strong>attaches <strong>glucose molecules to itself,</strong> starting the <strong>glycogen synthesis process</strong>, which is then <strong>extended by glycogen synthase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogenin is a 37 kDa protein (POLYPEPTIDE).</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogenin catalyses</strong> transfer of <strong>7 glucosyl residues from UDPGlucose,</strong> in alpha 1 &rarr; 4 linkage. Thus, glucosyl residues are added on specific tyrosine residues of Glycogenin.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogenin </strong>remains at the <strong>core of the Glycogen granule</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Harper 30/e p177.</span></strong></span></span></p>",
      "correct_choice_id": 30553,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9345,
      "choices": [
        {
          "id": 37347,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6 mercaptopurine</span></span></span></p>"
        },
        {
          "id": 37348,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Actinomycin D</span></span></span></p>"
        },
        {
          "id": 37349,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Puromycin </span></span></span></p>"
        },
        {
          "id": 37350,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of certain leukemias, a specific drug is utilized for its ability to interfere with the synthesis of nucleic acids, crucial for the proliferation of rapidly dividing cells. This drug achieves its therapeutic effect by inhibiting a key pathway in purine metabolism, indirectly affecting DNA replication. Which of the following medications is being described?</span></span></span></p>",
      "unique_key": "Q9254961",
      "question_audio": null,
      "question_video": null,
      "map_id": 29766,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>6 mercaptopurine</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>6-Mercaptopurine</strong> is an <strong>antimetabolite</strong> that <strong>interferes with purine nucleotide synthesis</strong> and <strong>metabolism,</strong> leading to the <strong>inhibition of DNA and RNA synthesis</strong>. This effect is particularly <strong>useful in the treatment</strong> of certain <strong>types of leukemia,</strong> where it can <strong>inhibit the proliferation</strong> of <strong>rapidly dividing leukemic cells</strong> by <strong>interfering with nucleic acid synthesis,</strong> thus indirectly inhibiting DNA replication.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Actinomycin D binds</strong> to <strong>DNA </strong>and <strong>inhibits RNA synthesis</strong> by <strong>preventing RNA polymerase </strong>from moving along the DNA, primarily affecting transcription rather than DNA replication directly.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Puromycin interferes</strong> with <strong>protein synthesis</strong> by causing <strong>premature chain termination</strong> during translation, which does not directly impact DNA replication.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Rifampicin inhibits bacterial RNA polymerase</strong>, thus affecting <strong>bacterial transcription.</strong> It is used primarily as an antibiotic and does not directly inhibit DNA replication in cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibitors of DNA replication: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture5.jpg\" style=\"height:407px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 586.</span></strong></span></span></p>",
      "correct_choice_id": 37347,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9326,
      "choices": [
        {
          "id": 37271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lesch-Nyhan Syndrome: Disorder of pyrimidine metabolism</span></span></span></p>"
        },
        {
          "id": 37272,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lesch-Nyhan Syndrome: Disorder of purine metabolism</span></span></span></p>"
        },
        {
          "id": 37273,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary Gout: Deficiency of Salvage Pathway</span></span></span></p>"
        },
        {
          "id": 37274,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Secondary Gout: Due to tumour lysis syndrome</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old boy is brought to the clinic by his mother, who is concerned about her son&#39;s repeated lip and finger biting and involuntary upper limb movements. She recalls noticing an orange discoloration in his diaper as an infant. Upon examination, the boy has multiple bite marks on his fingers and lips, and laboratory tests reveal a serum uric acid level of 9.5 mg/dl:</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/screenshot-2024-04-05-144013.png\" style=\"height:243px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Based on the clinical presentation and laboratory findings, what is the most probable diagnosis, and which metabolic pathway is affected in this disease?</span></span></span></p>",
      "unique_key": "Q2332906",
      "question_audio": null,
      "question_video": null,
      "map_id": 29781,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Lesch-Nyhan Syndrome: disorder of purine metabolism</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Lesch-Nyhan Syndrome</strong>: an <strong>X-linked inherited</strong> disorder of <strong>purine metabolism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Due to <strong>deficiency of HGPRTase</strong> &rarr; the <strong>rate of salvage pathway is decreased </strong>&rarr; accumulation of PRPP and decreased inhibitory purine nucleotides. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>C/F: </strong>Self-mutilation, mental retardation, excessive uric acid, nephrolithiasis, and Gout (later life). </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Treatment:&nbsp;</strong> Allopurinol. Since the salvage pathway is deficient, it is effective only to inhibit xanthine oxidase.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong><span style=\"font-size:12.0pt\"> <strong>Lesch-Nyhan Syndrome: </strong>Disorder of <strong>pyrimidine metabolism</strong>: This is incorrect because LNS is associated with purine, not pyrimidine, metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C</span></strong><span style=\"font-size:12.0pt\">. <strong>Primary Gout</strong>: Deficiency of <strong>Salvage Pathway</strong>: While gout involves hyperuricemia, the self-mutilating behavior and early onset are not typical of primary gout and indicate a more complex disorder like LNS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. <strong>Secondary Gout</strong>: Due to <strong>tumor lysis syndrome</strong>: Secondary gout can occur due to increased cell turnover, as seen in tumor lysis syndrome, but it does not explain the neurological and behavioral symptoms, nor is it common in children without a history of malignancy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Self-mutilating behaviors,</strong> <strong>neurological</strong> symptoms, and <strong>hyperuricemia </strong>is characteristic of <strong>Lesch-Nyhan Syndrome</strong> (LNS). <strong>LNS</strong> is a <strong>rare X-linked recessive disorder</strong> caused by a <strong>deficiency in the enzyme hypoxanthine-guanine phosphoribosyltransferase </strong>(HPRT), which is crucial in the <strong>purine salvage pathway.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><u>Ref</u>: Harper 30/e:&nbsp; p 354-355.</span></strong></span></span></p>",
      "correct_choice_id": 37272,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9341,
      "choices": [
        {
          "id": 37331,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypoxanthine phosphoribosyl transferase</span></span></span></p>"
        },
        {
          "id": 37332,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adenine phosphoribosyl transferase</span></span></span></p>"
        },
        {
          "id": 37333,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adenosine deaminase</span></span></span></p>"
        },
        {
          "id": 37334,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Purine nucleoside phosphorylase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 2-year-old child with a history of recurrent bacterial and viral infections, failure to thrive, developmental delays, and tremors is evaluated. Examination reveals an absence of peripheral lymphoid tissues. Laboratory findings indicate lymphopenia, with normal B-cell counts and immunoglobulin levels. Which enzyme deficiency is most likely responsible for this clinical presentation?</span></span></span></p>",
      "unique_key": "Q8711822",
      "question_audio": null,
      "question_video": null,
      "map_id": 29786,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. Purine nucleoside phosphorylase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options D</span></strong><span style=\"font-size:12.0pt\">.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>child has purine nucleoside phosphorylase deficiency</strong>, the reason is not yet fully elucidated, specially <strong>reduces T-cell counts </strong>but not B-cells. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Purine nucleoside phosphorylase</strong> is one of the <strong>salvage enzymes </strong>which <strong>converts guanosine </strong>or <strong>inosine </strong>to the <strong>free base plus ribose-1-phosphate. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options A.</span></strong><span style=\"font-size:12.0pt\"> <strong>Hypoxanthine phosphoribosyl transferase</strong> deficiency leads to <strong>Lesch-Nyhan syndrome</strong>, where there is no immune deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options B.</span></strong><span style=\"font-size:12.0pt\"> <strong>Adenine phosphoribosyl transferase</strong> deficiency leads to <strong>accumulation of an insoluble metabolite</strong> (2, 8-dihydroxyadenine) that precipitates in the kidney </span><span style=\"font-size:12.0pt\">ü°™</span><span style=\"font-size:12.0pt\">leads to renal failures.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Adenosine deaminase deficiency </strong>leads to an <strong>immune disorder </strong>where both B and T cells are deficient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Purine nucleoside phosphorylase</strong> (PNP) deficiency leads to a <strong>selective T-cell deficiency,</strong> part of the <strong>spectrum of SCID disorders.</strong> Despite <strong>normal B-cell counts</strong> and <strong>immunoglobulin levels,</strong> the lack of T-cell help results in functional impairment of B-cells, leading to recurrent infections.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Vasudevan 9/e: p585.</span></strong></span></span></p>",
      "correct_choice_id": 37334,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}